Noseda A - Search Results

1

Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.

Ghione S, Genovesi-Ebert A, Marabotti C, Spinazzi A, Noseda A. Ghione S, et al. Among authors: noseda a. Blood Press Suppl. 1994;4:25-30. Blood Press Suppl. 1994. PMID: 7804509 Review.

2

Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension.

Genovesi-Ebert A, Marabotti C, Palombo C, Ghione S, Cattaneo G, Noseda A, Spinazzi A. Genovesi-Ebert A, et al. Among authors: noseda a. Eur Heart J. 1992 Jun;13 Suppl A:45-8. doi: 10.1093/eurheartj/13.suppl_a.45. Eur Heart J. 1992. PMID: 1356776 Clinical Trial. No abstract available.

3

Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus.

Fariello R, Boni E, Corda L, Zaninelli A, Noseda A, Spinazzi A. Fariello R, et al. Among authors: noseda a. Eur Heart J. 1992 Jun;13 Suppl A:65-9. doi: 10.1093/eurheartj/13.suppl_a.65. Eur Heart J. 1992. PMID: 1356779 Clinical Trial. No abstract available.

4

Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.

Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A. Spinazzi A, et al. Among authors: noseda a. Cancer Detect Prev. 1994;18(3):209-20. Cancer Detect Prev. 1994. PMID: 8076383

5

Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein(a) in patients with coronary, epiaortic and peripheral occlusive artery disease.

Caputo M, Mantini G, Floriani I, Ciceri M, Noseda A, Bonomo L. Caputo M, et al. Among authors: noseda a. Eur Heart J. 1996 Sep;17(9):1329-36. doi: 10.1093/oxfordjournals.eurheartj.a015066. Eur Heart J. 1996. PMID: 8880017

6

Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity.

Diomede L, Bizzi A, Magistrelli A, Modest EJ, Salmona M, Noseda A. Diomede L, et al. Among authors: noseda a. Int J Cancer. 1990 Aug 15;46(2):341-6. doi: 10.1002/ijc.2910460234. Int J Cancer. 1990. PMID: 2384281

7

Increased ether lipid cytotoxicity by reducing membrane cholesterol content.

Diomede L, Piovani B, Modest EJ, Noseda A, Salmona M. Diomede L, et al. Among authors: noseda a. Int J Cancer. 1991 Sep 30;49(3):409-13. doi: 10.1002/ijc.2910490317. Int J Cancer. 1991. PMID: 1917140

8

Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.

Floriani I, Ciceri M, Torri V, Tinazzi A, Jahn H, Noseda A. Floriani I, et al. Among authors: noseda a. Invest Radiol. 1996 Aug;31(8):479-91. doi: 10.1097/00004424-199608000-00003. Invest Radiol. 1996. PMID: 8854194

9

Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study.

Noseda A, White JG, Godwin PL, Jerome WG, Modest EJ. Noseda A, et al. Exp Mol Pathol. 1989 Feb;50(1):69-83. doi: 10.1016/0014-4800(89)90057-9. Exp Mol Pathol. 1989. PMID: 2920821

10

Effects of antineoplastic ether lipids on model and biological membranes.

Noseda A, Godwin PL, Modest EJ. Noseda A, et al. Biochim Biophys Acta. 1988 Nov 3;945(1):92-100. doi: 10.1016/0005-2736(88)90366-5. Biochim Biophys Acta. 1988. PMID: 3179313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters